Our history

JAMP Pharma Group is about committed people who together think big for our communities.

Meet our executive committee

Our Executive Committee strives to accomplish our mission of providing and ensuring the availability of top quality medicines and healthcare solutions.

1988

Foundation of JAMP

Main objectif: subcontracting manufacturing
2006

Louis Pilon becomes CEO

and takes the company on the path of growth
2007

Wampole acquisition

OTC medication
2007

Launch of the first JAMP generic molecule
2010

Creation of Orimed

to develop and market branded products
2013

Acquisition of Laboratoire Suisse

Natural products
2014

Acquisition of Cosmetic Import

Health and beauty products
2016

JAMP Pharma moves

to a new office
2017

McKesson Award

Recipient of the D.W. Bole prize awarded by McKesson for excellence in supply chain and product availability
2018

Anniversary

JAMP Pharma is 30 years old!
2020

Expansion of the Boucherville office
2022

Launch of BIOJAMP division

et du premier biosimilaire

Who we are

JAMP Pharma Group is a private Canadian company that was launched in 1988. Originally a contract manufacturing organization¹ (CMO), the company now provides high-quality medicines and health solutions for patients and consumers.

Our activities are vertically integrated at our headquarters just outside of Montréal, in Canada; from commercial operations to the delivery of pharmaceutical products, we boast:

Fully integrated commercial operations
Warehousing
Quality assurance laboratory
Vault storage for controlled substances
Cold chain maintenance capabilities

With one of the largest sales forces in the Canadian generic industry, as well as a dedicated sales force for our branded products, we are well equipped to provide personalized support to partners and healthcare professionals across Canada. Not only do we supply more than 11,500 pharmacies from coast to coast, but physicians also demonstrate their trust in us by choosing to prescribe our branded products.

Our history

Meet our executive committee

History of JAMP Pharma Group

1988

Foundation of JAMP

2006

Louis Pilon becomes CEO

2007

Wampole acquisition

2007

Launch of the first JAMP generic molecule

2010

Creation of Orimed

2013

Acquisition of Laboratoire Suisse

2014

Acquisition of Cosmetic Import

2016

JAMP Pharma moves

2017

McKesson Award

2018

Anniversary

2020

Expansion of the Boucherville office

2022

Launch of BIOJAMP division

Our vision is to become the largest Canadian-owned pharmaceutical company.